Differential responsiveness of the rat dorsal and median raphe 5‐HT systems to 5‐HT1 receptor agonists and p‐chloroamphetamine
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The dorsal and median raphe 5‐HT neurons give rise to projections that differ in axon morphology and in vulnerability to certain amphetamine derivatives. The present study was undertaken to determin if these two 5‐HT systems possess different functional properties. To this end, we studied the effects of selective 5HT 1A or 5‐HT 1A/5‐HT 1B receptor agonists and of p‐chloroamphetamine on extracellular levels of indoleamines, as measured by differential pulse voltammetry with electrochemically pretreated carbon fiber electrodes, in cell body and nerve terminal regions of these subsets of 5‐HT neurons in the rat brain. The selective 5‐HT 1A agonist 8‐OH‐DPAT produced a gradual decrease in the height of 300mV oxidation peak in the dorsal raphe and in the frontal cortex, reaching a maximum of 60% 3 h after the i.v. injection of 30 m̈g/kg. However, the same dose of 8‐OH‐DPAT was ineffective in the median raphe and in the dentate gyrus that receives its 5‐HT innervation exclusively from the median raphe. A higher dose of 8‐OH‐DPAT (150 m̈g/kg, i.v.) produced a 60% decrease in the height of the 300 mV oxidation peak in the median raphe, whereas only a 20% decrease was obtained in the dentate gyrus. In contrast, the non‐selective 5‐HT 1 agonist RU 24 969 (10 mg/kg, i.p.) caused 70% reduction of the 300 mV peak height in both the dorsal and median raphe and a 50% decrease in both the frontal cortex and the dentate gyrus. Moreover, although a high dose of 8‐OH‐DPAT (150 m̈g/kg, i.v.) given alone reduced by 20% the amplitude of the oxidative peak in the dentate gyrus, subsequent administration of RU 24 969 (10 mg/kg, i.p.) caused a further 30% diminution of the oxidative peak height. The greater responsiveness of dorsal as compared to median raphe 5‐HT systems to 5‐HT 1A receptor agonists was confirmed in two further series of experiments. First, the microiontophoretic application of 8‐OH‐DPAT directly onto 5‐HT neurons was three times more potent in suppressing the firing rate of dorsal raphe 5HT neurons than that of their median raphe congeners. Second, 8‐OH‐DPAT and buspirone were ten and four times, respectively, more potent in decreasing 5‐HT skynthesis in the frontal cortex than in the hippocampus. Three hours after the administration of p‐chloroamphetamine (5 mg/kg, i.p.), the height of the 300 mV peak was increased by 60% in the frontal cortex but was unchanged in the dentate gyrus. The following conclusions can be drawn from the present investigation: (1) the dorsal raphe‐frontal cortex 5‐HT system exhibits a greater responsiveness of a 5‐HT 1A agonist than does the median raphe‐dentate gyrus 5‐HT system; (2) in the latter system, 5‐HT 1A receptor activation caused a greater reduction in extracellular indoleamines at the level of the cell bodies than in the corresponding terminal fields (dentate gyrus); (3) the terminal 5‐HT 1B autoreceptor seems to play a more important role in the control of 5‐HT release in the dentate gyrus than in the frontal cortex; and (4) 5‐HT terminals in the dentate gyrus appear to be insensitive to the 5‐HT‐releasing effect of p‐chloramphetamine, which is consistent with the inability of this drug to destroy 5‐HT terminals in that region of the brain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The inhibitory actions of acute escitalopram administration on terminal 5-HT release, through actions at auto-receptors on raphé 5-HT neurons [8], may be analogous to the presumed transient reduction in 5-HT activity caused by ATD [49].”
From Dissociable effects of acute SSRI (escitalopram) on executive, learning and emotional functions in healthy humans (2018) · cites this paper as [8]
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Stereotaxic mapping of the monoamine pathways in the rat brain
Ungerstedt, U. (1971) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.1971.tb10998.x · Cited by 3,819 · cited 1×
“The serotonin (5-HT) axons innervating the forebrain originate almost entirely from the dorsal and median raphe nuclei (Dahlstrom and Fuxe, 1964; Anden et al., 1966; Ungerstedt, 1971).”
BackgroundAzmitia, E. C., & Segal, M. (1978) · Journal of Comparative Neurology · doi:10.1002/cne.901790311 · Cited by 1,909
Ascending Monoamine Neurons to the Telencephalon and Diencephalon
Andén, N. ‐., Dahlström, A., Fuxe, K., Larsson, K., Olson, L., & Ungerstedt, U. (1966) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1966.tb03318.x · Cited by 1,214
Paxinos, G., & Watson, C. (1982) · The Rat Brain in Stereotaxic Coordinates · doi:10.1016/b978-0-12-547620-1.50007-2 · Cited by 824
Engel, G., G�thert, M., Hoyer, D., Schlicker, E., & Hillenbrand, K. (1986) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00633189 · Cited by 677
Hoyer, D., Engel, G., & Kalkman, H. O. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90658-2 · Cited by 574
O'Hearn, E., Battaglia, G., De Souza, E., Kuhar, M., & Molliver, M. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02788.1988 · Cited by 542
Blier, P., & De Montigny, C. (1987) · Synapse · doi:10.1002/syn.890010511 · Cited by 426
Self-citationKosofsky, B. E., & Molliver, M. E. (1987) · Synapse · doi:10.1002/syn.890010204 · Cited by 412 · cited 3×
“More recently, it was demonstrated that 5-HT axons arising from the dorsal and the median raphe are morphologically dissimilar: dorsal raphe fibers are very fine and have small granular or fusiform varicosities, whereas median raphe fibers are relatively coarse with large spherical varicosities (Kosofsky and Molliver,…”
BackgroundInfluential
Research works printed but not linked: 7
- Berger U., 1987, Psychotropic amphetamines have different sites of action at serotonergic (5‐HT): synapses: A comparison of p‐chloroamphetamine (PCA), and 3,4‐methylenedioxyamphetamine (MDA): with 2,5‐dimethoxy4‐methylamphetamine (DOM), Soc. Neurosci. Abstr., 13, 906
- Cespuglio R., 1984, Monoamine Innervation of Cerebral Cotex, 279
- Dahlstrom A., 1964, Evidence for the existence of monoamine‐containing neurons in the central nervous system. I. Demonstration of monoamines in cell bodies of brain neurons, Acta Physiol. Scand. (Suppl. 0. 232), 62, 1
- Fritschy J. M., 1987, Serotonergi (5‐HT): projections from dorsal raphe, raphe obscurus, and raphe pallidus to the motor nucleus of the trigeminal nerve: Differential vulnerability of their axon terminals to p‐chloroamphetamine (PCA), Soc. Neurosci. Abstr., 13, 907
- Maidment N. T., 1986, Monitoring Neurotransmitter Release During Behaviour, 73
- Mamounas L. A., 1987, Dual serotonergic projections to forebrain have separate origins in the dorsal and median raphe nuclei: Retrograde transport after selective axonal ablation by para‐chloramphetamine (PCA), Soc. Neurosci. Abstr., 13, 907
- Neckers L. M., 1976, Concentration in certain rat brain nuclei after p‐chloroamphetamine, J. Pharmacol. Exp. Ther., 196, 333
Cited by
A review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,161
“…in the dorsal raphe nucleus are more sensitive to 5-HT1A receptor agonists than 5-HT neurones in the median raphe nucleus (Sinton and Fallon, 1988; Blier et al., 1990), although other data do not confirm this (VanderMaelen and Braselton, 1990; Hajós et al., 1995; Gartside et al., 1997a,b).”
ResultSerotonin receptor 1A knockout: An animal model of anxiety-related disorder
Ramboz, S., Oosting, R., Amara, D. A., Kung, H. F., Blier, P., Mendelsohn, M., Mann, J. J., Brunner, D., & Hen, R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14476 · Cited by 814
Self-citationAutoregulation of Serotonin Neurons: Role in Antidepressant Drug Action
Piñeyro, G., & Blier, P. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01417-0 · Cited by 537
“the local application of such drugs (Blier et al., 1990).”
Self-citationMongeau, R., Blier, P., & de Montigny, C. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(96)00017-3 · Cited by 389
Self-citationSerotonin and psychostimulant addiction: Focus on 5-HT1A-receptors
Müller, C. P., Carey, R. J., Huston, J. P., & De Souza Silva, M. A. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.01.001 · Cited by 302
Sotelo, C., Cholley, B., El Mestikawy, S., Gozlan, H., & Hamon, M. (1990) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1990.tb00026.x · Cited by 284
Effects of centrally administered anxiolytic compounds in animal models of anxiety
Menard, J., & Treit, D. (1999) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(98)00056-6 · Cited by 283
The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour
Steckler, T., & Sahgal, A. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(94)00157-b · Cited by 281
Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei
Adell, A., Celada, P., Abellán, M. T., & Artigas, F. (2002) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00182-0 · Cited by 254
ADELL, A., CASANOVAS, J. M., & ARTIGAS, F. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00048-8 · Cited by 229
Hjorth, S., & Sharp, T. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90216-x · Cited by 211
Maximino, C., Puty, B., Benzecry, R., Araújo, J., Lima, M. G., de Jesus Oliveira Batista, E., Renata de Matos Oliveira, K., Crespo-Lopez, M. E., & Herculano, A. M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.03.006 · Cited by 206
“…of rodents (Casanovas and Artigas, 1996; Casanovas et al., 2000, 1997), inhibits the firing of putative serotonergic neurons in vivo and in vitro (Blier et al., 1990; Casanovas et al., 2000; Sinton and Fallon, 1988), and decreases nitric oxide synthase isoform 1 (NOS-1), but not tryptophan…”
BackgroundSerotonin autoreceptor function and antidepressant drug action
Hjorth, S., Bengtsson, H. J., Kullberg, A., Carlzon, D., Peilot, H., & Auerbach, S. B. (2000) · Journal of Psychopharmacology · doi:10.1177/026988110001400208 · Cited by 191
“Moreover, although some electrophysiological data suggest that the sensitivity of 5-HT1A autoreceptors in the MR to 5-HT1A receptor agonists or SSRIs is lower than in the DR, other studies find no significant difference among the two raphe nuclei in this respect (Sinton and Fallon, 1988; Blier et al., 1990; Hajos et a…”
BackgroundResultMedian and Dorsal Raphe Neurons Are Not Electrophysiologically Identical
Beck, S. G., Pan, Y.-Z., Akanwa, A. C., & Kirby, L. G. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00744.2003 · Cited by 166
Romero, L., & Artigas, F. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68062593.x · Cited by 152
“…by selective agonists has been reported to cause a greater reduction of activity in 5-HT neurons of the dorsal raphe nucleus (Sinton and Fallon, 1988; Blier et al., 1990) and of 5-HT synthesis and release from the corresponding axon terminals (Invernizzi et al., 1991; Casanovas and Artigas, 1996).”
BackgroundResultAndrews, N., Hogg, S., Gonzalez, L. E., & File, S. E. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)00473-0 · Cited by 148
Tao, R., Ma, Z., & Auerbach, S. B. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb16049.x · Cited by 146
Obsessive-compulsive disorder in schizophrenia: epidemiologic and biologic overlap.
Tibbo, P. G., & Warneke, L. B. (1999) · PubMed · Cited by 173
Bonvento, G., Scatton, B., Claustre, Y., & Rouquier, L. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90308-t · Cited by 125
Self-citationEffect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors
Hervás, I., & Artigas, F. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00579-2 · Cited by 123
Increased brain serotonin synthesis in migraine
Chugani, D. C., Niimura, K., Chaturvedi, S., Muzik, O., Fakhouri, M., Lee, M.-L., & Chugani, H. T. (1999) · Neurology · doi:10.1212/wnl.53.7.1473 · Cited by 121
Haj�s, M., Gartside, S. E., & Sharp, T. (1995) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00170162 · Cited by 117
“Microiontophoretic studies also detected that the MRN was less sensitive to 8-OH-DPAT than the DRN although the potency difference was only of the order of 3 times (Blier et al. 1990).”
Dobson, C., Tohyama, Y., Diksic, M., & Hamel, E. (2004) · Cephalalgia · doi:10.1111/j.1468-2982.2004.00647.x · Cited by 113
Hajós, M., Gartside, S. E., Villa, A. E. P., & Sharp, T. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00227-a · Cited by 112
Casanovas, J. M., Lésourd, M., & Artigas, F. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701420 · Cited by 104
“Initial electrophysiological studies demonstrated a greater sensitivity of DRN neurones to the ®ring-suppressant actions of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) (Sinton & Fallon, 1988; Blier et al., 1990), a view challenged by more recent data (Hajos et al., 1995).”
ResultSerotonin Receptor Subtypes: Implications for Psychopharmacology
Cowen, P. J. (1991) · British Journal of Psychiatry · doi:10.1192/s0007125000296190 · Cited by 97
Skandali, N., Rowe, J. B., Voon, V., Deakin, J. B., Cardinal, R. N., Cormack, F., Passamonti, L., Bevan-Jones, W. R., Regenthal, R., Chamberlain, S. R., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0229-z · Cited by 89
Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation
Rutter, J. J., Gundlah, C., & Auerbach, S. B. (1995) · Synapse · doi:10.1002/syn.890200306 · Cited by 96
Parsons, L. H., Kerr, T. M., & Tecott, L. H. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00254.x · Cited by 93
“Whereas the frontal cortex serotonergic innervation arises preferentially from the DRN, the ventral hippocampus receives serotonergic afferents arising predominantly from the MRN (Azmitia and Segal 1978; Molliver 1987; Vertes and Martin 1988; Vertes 1991; Vertes et al. 1999).”
BackgroundInfluentialPage, M. E., Cryan, J. F., Sullivan, A., Dalvi, A., Saucy, B., Manning, D. R., & Lucki, I. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034280 · Cited by 92
“…of the HPv by MR fibers (Kosofsky and Molliver, 1987) and greater responsiveness of DR neurons to the autoinhibitory actions of 5-HT on 5-HT1A receptors (Sinton and Fallon, 1988; Blier et al., 1990; Romero and Artigas, 1997) may contribute to regional differences in the response to SSRIs.”
BackgroundCox, R. F., Meller, E., & Waszczak, B. L. (1993) · Synapse · doi:10.1002/syn.890140407 · Cited by 87
Rouquier, L., Claustre, Y., & Bénavidès, J. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90300-x · Cited by 86
Piñeyro, G. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00109-q · Cited by 84
Okazawa, H., Yamane, F., Blier, P., & Dikšić, M. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722022.x · Cited by 81
“de Montigny, 1987), of 5-HTP accumulation (Hjorth and Carlsson, 1982; Blier et al., 1990; Tunnicliff et al., 1992), and of extracellular 5-HT concentration assessed by intracerebral microdialysis (Sharp et al.”
BackgroundMethodSelf-citationLowry, C. A., Evans, A. K., Gasser, P. J., Hale, M. W., Staub, D. R., & Shekhar, A. (2008) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8561-3_2 · Cited by 109
Fletcher, P. J., Ming, Z.-H., & Higgins, G. A. (1993) · Psychopharmacology · doi:10.1007/bf02244330 · Cited by 74
“D P A T in terms of elect rophysiological activity (Sinton and Fa l lon 1988; Blier et al. 1990) and behavioura l effects (Higgins and Elliott 1991; Fletcher, 1993).”
BackgroundGur, E., Lerer, B., & Newman, M. E. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37927-3 · Cited by 73
Effects ofp-chloroamphetamine on brain serotonin neurons
Fuller, R. W. (1992) · Neurochemical Research · doi:10.1007/bf00969891 · Cited by 72
Selvaraj, S., Turkheimer, F., Rosso, L., Faulkner, P., Mouchlianitis, E. D., Roiser, J. P., McGuire, P. K., Cowen, P. J., & Howes, O. D. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.78 · Cited by 70
Inhibition of 5-hydroxytryptamine neuronal activity by the 5-HT agonist, DOI
Garratt, J. C., Kidd, E. J., Wright, I. K., & Marsden, C. A. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90499-g · Cited by 74
A microdialysis study of the in vivo release of 5‐HT in the median raphe nucleus of the rat
Adell, A., & Artigas, F. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702206 · Cited by 65
“Both nuclei also show di erences in the sensitivity to neurotoxins (Mamounas & Molliver, 1988; Blier et al., 1990), agonists at somatodendritic 5-HT1A autoreceptors (Sinton & Fallon, 1988; Hillegaart et al., 1990; Invernizzi et al., 1991; Casanovas et al., 1997) and in the response to aversive…”
BackgroundBlier, P. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00318-4 · Cited by 63
“…that the administration of 8-OH-DPAT, which suppresses the firing activity of 5-HT neurons in the median and dorsal raphe (Sinton and Fallon 1988; Blier et al. 1990), and consequently reduces 5-HT release in the hypothalamus (Auerbach et al. 1989), would induce hypothermia by such a presynaptic…”
BackgroundSelf-citationKnobelman, D. A., Hen, R., Blendy, J. A., & Lucki, I. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29478-7 · Cited by 63
“…studies in rats have suggested that DR-innervated regions may more sensitive to the effects of 5-HT1A receptor agonists than MRinnervated regions (Blier et al., 1990; Casanovas and Artigas, 1996; Casanovas et al., 1997), although these regional differences for 8-OH-DPAT have not been shown…”
Lambás‐Señas, L., Mnie‐Filali, O., Certin, V., Faure, C., Lemoine, L., Zimmer, L., & Haddjeri, N. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.11.017 · Cited by 75
“Inhibition of firing activity of 5HT DR neurons and 5-HT release by OH-DPAT has been attributed to the activation of somatodendritic DR 5-HT1A autoreceptors (Blier et al., 1990; Sharp et al., 1989).”
BackgroundLemos, J. C., Pan, Y., Ma, X., Lamy, C., Akanwa, A. C., & Beck, S. G. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05222.x · Cited by 62
Clement, H., Schäfer, F., Ruwe, C., Gemsa, D., & Wesemann, W. (1993) · Brain Research · doi:10.1016/0006-8993(93)91024-m · Cited by 62
Auerbach, S. B., & Hjorth, S. (1995) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00171317 · Cited by 61
Bolaños, F. J., Manhães‐de‐Castro, R., Seguin, L., Cloëz-Tayarani, I., Monneret, V., Drieu, K., & Fillion, G. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00590-0 · Cited by 60
Roberts, C., Belenguer, A. M., Middlemiss, D. N., & Routledge, C. A. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00061-2 · Cited by 59
Saito, H., Matsumoto, M., Togashi, H., & Yoshioka, M. (1996) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.70.203 · Cited by 62
Sharp, T., McQuade, R., Bramwell, S. R., & Hjorth, S. (1993) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00171331 · Cited by 65
Houdouin, F., Cespuglio, R., Gharib, A., Sarda, N., & Jouvet, M. (1991) · Experimental Brain Research · doi:10.1007/bf00229997 · Cited by 58
Kuroki, T., Ichikawa, J., Dai, J., & Meltzer, H. Y. (1996) · Brain Research · doi:10.1016/s0006-8993(96)01111-0 · Cited by 56
Ligands for the investigation of 5-HT autoreceptor function
Roberts, C., Price, G. W., & Middlemiss, D. N. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00628-1 · Cited by 55
Clement, H. ‐., Gemsa, D., & Wesemann, W. (1992) · Journal of Neural Transmission · doi:10.1007/bf01245033 · Cited by 54
Comparison of buspirone with diazepam and fluvoxamine on aversive classical conditioning in humans
Hellewell, J. S. E., Guimaraes, F. S., Wang, M., & Deakin, J. F. W. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300202 · Cited by 53
“Buspirone's action on pre-synaptic soma-dendritic autoreceptors reduces the ®ring rate of 5-HT neurones in the raphe and this is particularly marked in the dorsal raphe nucleus (Blier et al., 1990).”
BackgroundQuednow, B. B., K�hn, K.-U., Stelzenmueller, R., Hoenig, K., Maier, W., & Wagner, M. (2003) · Psychopharmacology · doi:10.1007/s00213-004-1842-6 · Cited by 54
“…an anxiolytic agent which reduces activity in serotonin neurons via action at presynaptic somadendritic 5-HT1A autoreceptors in the raphe (Blier et al. 1990), accelerated habituation of the skin conductance response in an aversive classical conditioning paradigm with acoustic stimuli in…”
BackgroundSerotonin in antipsychotic drugs action
Amato, D. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.025 · Cited by 58
Ferretti, C., Blengio, M., Gamalero, S. R., & Ghi, P. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00172-h · Cited by 51
Recognition memory in rats—III. Neurochemical substrates
Steckler, T., Sahgal, A., Aggleton, J. P., & Drinkenburg, W. H. I. M. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00062-2 · Cited by 59
Roberts, C., Price, G. W., & Jones, B. J. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00156-8 · Cited by 50
Hervás, I., Bel, N., Fernández, A. G., Palacios, J. M., & Artigas, F. (1998) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005259 · Cited by 49
“Data in the literature support a preferential reduction of 5-HT metabolism and release in forebrain areas selectively innervated by neurones of the dorsal raphe nucleus (DRN) such as frontal cortex or dorsal striatum after the local or systemic activation of 5-HT 1A receptors ( Blier et al. 1990; Invernizzi et al. 199…”
BackgroundMartín, F. J. E. S., & Artigas, F. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08356.x · Cited by 49
Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia
Navailles, S., & Deurwaerdère, P. D. (2011) · Parkinson's Disease · doi:10.1155/2012/323686 · Cited by 51
Melega, W. P., Quintana, J., Raleigh, M. J., Stout, D. B., Yu, D.-C., Lin, K.-P., Huang, S.-C., & Phelps, M. E. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199601)22:1<63::aid-syn7>3.0.co;2-g · Cited by 43
Self-citationRoberts, C., Boyd, D. F., Middlemiss, D. N., & Routledge, C. A. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00051-9 · Cited by 45
Functional characterization of the 5‐HT terminal autoreceptor in the guinea‐pig brain cortex
Roberts, C., Watson, J., Burton, M. J., Price, G. W., & Jones, B. J. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15203.x · Cited by 44
Dawson, L. A., Hughes, Z. A., Starr, K. R., Storey, J. D., Bettelini, L., Bacchi, F., Arban, R., Poffe, A., Melotto, S., Hagan, J. J., et al. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.01.010 · Cited by 42
Müller, C. P., Carey, R. J., Salloum, J. B., & Huston, J. P. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00046-7 · Cited by 45
P-chloroamphetamine induces C-fos in rat brain: A study of serotonin2A/2C receptor function
Moorman, J. M., & Leslie, R. A. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00553-6 · Cited by 41
Daws, L. C., Toney, G. M., Davis, D. J., Gerhardt, G. A., & Frazer, A. (1997) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(97)00144-1 · Cited by 40
Serotonin in the inferior colliculus fluctuates with behavioral state and environmental stimuli
Hall, I. C., Rebec, G. V., & Hurley, L. M. (2010) · Journal of Experimental Biology · doi:10.1242/jeb.035956 · Cited by 42
Casanovas, J. M., Berton, O., Celada, P., & Artigas, F. (2000) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000291 · Cited by 38
Newman, M. E., Gur, E., Dremencov, E., García, F., Lerer, B., & de Kar, L. D. V. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00077-0 · Cited by 38
Carey, R. J., Huston, J. P., & Müller, C. P. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00917-5 · Cited by 40
Bonnavion, P., Bernard, J., Hamon, M., Adrien, J., & Fabre, V. (2010) · Journal of Comparative Neurology · doi:10.1002/cne.22331 · Cited by 36
“…neurons in the DR than in the MnR and for decreasing 5-HT release in brain regions that receive a preferential DR innervation than in those mainly innervated by the MnR (Blier et al., 1990; Invernizzi et al., 1991; Casanovas and Artigas, 1996; Beck et al., 2004; Judge and Gartside, 2006).”
BackgroundGartside, S. E., McQuade, R., & Sharp, T. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00171-8 · Cited by 34
Xu, X., Zheng, C., An, L., Wang, R., & Zhang, T. (2016) · Brain Topography · doi:10.1007/s10548-016-0485-3 · Cited by 36
Adaptative Changes of the Serotonergic System After Antidepressant Treatments
Artigas, F., Bel, N., Casanovas, J. M., & Romero, L. I. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4613-0381-7_6 · Cited by 35
Rapid desensitization of 5-HT1A receptors in Fawn-Hooded rats after chronic fluoxetine treatment
Kántor, S., Gráf, M., Anheuer, Z. E., & Bagdy, G. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)00126-7 · Cited by 35
Neuroplastic effects of a selective serotonin reuptake inhibitor in relearning and retrieval
Reed, M. B., Vanicek, T., Seiger, R., Klöbl, M., Spurny‐Dworak, B., Handschuh, P. A., Ritter, V., Unterholzner, J., Godbersen, G. M., Gryglewski, G., et al. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118039 · Cited by 35
“Previous studies suggest that the SSRI escitalopram facilitates reearning and memory consolidation in HC ( Harmer et al., 2002 ; rown et al., 2012 ).”
ResultMokler, D. J., Bronzino, J. D., Galler, J. R., & Morgane, P. J. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01677-7 · Cited by 32
Ruotsalainen, S., Miettinen, R. A., MacDonald, E., Riekkinen, M., & Sirviö, J. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00065-6 · Cited by 32
Judge, S. J., & Gartside, S. E. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.09.003 · Cited by 32
Johnson, M. D. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90522-3 · Cited by 30
5-Hydroxytryptamine release in dorsal hippocampus of freely moving rats: Modulation by pindolol
Bosker, F. J., Donker, M. G., Klompmakers, A. A., Kurata, K., & Westenberg, H. G. M. (1994) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)90083-3 · Cited by 25
Abellán, M. T., Martín‐Ruiz, R., & Artigas, F. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)00118-8 · Cited by 22
Sulaiman, P., Joseph, B., & Paulose, C. S. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.12.003 · Cited by 21
“5-HT2C receptors [formerly termed 5-HT1C] are widely expressed in the brain and appear to mediate many important effects of 5-HT [11,12].”
Hossain, M. M., Suzuki, T., Richardson, J. R., & Kobayashi, H. (2012) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21450 · Cited by 20
Strategies to Optimize the Antidepressant Action of Selective Serotonin Reuptake Inhibitors
Romero, L. I., Casanovas, J. M., Hervás, I., Cortés, R., & Artigas, F. (1997) · Humana Press eBooks · doi:10.1007/978-1-59259-474-0_1 · Cited by 20
Neural serotonergic circuits for controlling long-term voluntary alcohol consumption in mice
Belmer, A., Depoortère, R., Beecher, K., Newman‐Tancredi, A., & Bartlett, S. E. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01789-z · Cited by 20
Physiology and Pharmacology of Brain Serotoninergic Neurons
Jacobs, B., & Fornal, C. A. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60921-3_3 · Cited by 18
SB‐236057‐A: A Selective 5‐HT 1B Receptor Inverse Agonist
Roberts, C., Watson, J. M., Price, G. W., & Middlemiss, D. N. (2001) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2001.tb00209.x · Cited by 18
Dremencov, E., Gur, E., Lerer, B., & Newman, M. E. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)00078-x · Cited by 21
Ridet, J., Geffard, M., & Privat, A. (1994) · The Journal of Comparative Neurology · doi:10.1002/cne.903430208 · Cited by 17
Herges, S., & TAYLOR, D. A. H. B. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00333-7 · Cited by 17
Nguyen, K. Q., Tohyama, Y., Watanabe, A., Hasegawa, S., Skelin, I., & Dikšić, M. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.08.012 · Cited by 16
“The gradualness of these changes likely underlies the delay in therapeutic onset that is characteristic of SSRI therapy (Blier et al., 1990a).”
BackgroundCalcagno, E., Guzzetti, S., Canetta, A., Fracasso, C., Caccia, S., Cervo, L., & Invernizzi, R. W. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009760 · Cited by 17
Brambilla, A., Baschirotto, A., Grippa, N., & Borsini, F. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00056-5 · Cited by 15
Larsson, L.-G., Stenfors, C., & Ross, S. B. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00073-9 · Cited by 15
Metadata
- Authors
- Blier, P., Serrano, A., & Scatton, B.
- Venue
- Synapse
- Publisher
- Wiley
- Published
- 1990-01
- Volume
- 5
- Issue
- 2
- Pages
- 120-133
- ISSN
- 0887-4476 (ISSN-L)
- 1098-2396
- OpenAlex
- W2029748309
- Cited by
- 123
- References
- 31
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2018: 2 · 2016: 1 · 2014: 1 · 2013: 1 · 2012: 4
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Synapse (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- dorsal raphe nucleus, median raphe, serotonergic neurons, 5-HT1A receptor agonist, 5-HT1B receptor agonist, p-chloroamphetamine, amphetamine derivatives, 8-OH-DPAT, serotonin nerve terminals, dentate gyrus, frontal cortex, differential pulse voltammetry, carbon fiber electrodes
- MeSH terms
- Action Potentials, Amphetamines, Animals, Indoles, Male, Naphthalenes, p-Chloroamphetamine, Raphe Nuclei, Rats, Inbred Strains, Receptors, Serotonin, Serotonin, Tetrahydronaphthalenes, 8-Hydroxy-2-(di-n-propylamino)tetralin, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.